However, the primary driver mutations of NSCLC are epidermal growth factor receptor (EGFR), with 10–35% frequency, and Kirsten rat sarcoma (KRAS), with 25% frequency [7]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.